Amniotic Fluid Lactate in Perterm Premature Rupture of Membranes

Amniotic Fluid Lactate in Predicting Latency in Perterm Premature Rupture of Membranes

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03789903

Enrollment

Registered

2018-12-31

Start date

2018-01-01

Completion date

2019-03-01

Last updated

2018-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rupture of Membranes; Premature

Brief summary

AF lactate level could help in predicting the duration from ROM till delivery

Interventions

DIAGNOSTIC_TESTamniotic fluid lactate

AF lactate

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 35 Years

Healthy volunteers

Inclusion criteria

1. women with PPROM 2. GA between 24 to 34 weeks

Exclusion criteria

1. chorioamnionitis 2. previous Preterm labor 3. abruptio placentae 4. UTI ,pyelonephritis

Design outcomes

Primary

Measure	Time frame	Description
latency period	upto 48 hours	duration from ROM till the occurrence of active labor

Countries

Egypt

Contacts

Primary ContactRadwa R Ali, MD

radwaebed@yahoo.com01283492979

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026